• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LIT
Click for more information
0.00% 2.1¢

LITHIUM AUSTRALIA LIMITED - Corporate Spotlight

Market Cap $27.32M  ! watchlist Created with Sketch. Add to my watchlist
Industrials

Lithium Australia Limited is an Australia-based company, which develops processing... Lithium Australia Limited is an Australia-based company, which develops processing technology to produce lithium ferro phosphate, and also develops lithium extraction technology. The Company's Lithium Chemicals segment consists of research and development of a suite of extraction and refining technologies for the recovery of lithium chemicals from various materials, including spodumene, lithium micas and end of life lithium-ion batteries. Its Battery Materials segment provides research and development of advanced, battery materials, including lithium ferro phosphate and lithium manganese ferro phosphate. Its Battery Recycling segment offers research and development of processing technology for mixed-battery recycling, as well as the sale of recovered energy metals. The Company shreds and recycles all types of end-of-life batteries at its Melbourne facilities. Its process involves recovery of energy metals as a mixed metal dust, which is then exported for further refining.More

No Corporate Spotlight currently available.

(20min delay)
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $27.32M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $34.87K 1.656M

Buyers (Bids)

No. Vol. Price($)
15 1869519 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 772833 6
View Market Depth
Last trade - 16.10pm 03/10/2024 (20 minute delay) ?
Last
2.1¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
2.2¢ 2.2¢ 2.1¢ 340698
Last updated 15.17pm 03/10/2024 ?
LIT (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20% Chariot has unveiled its vision for its US-based Black Mountain – aiming to fast-track its path to production by establishing a "pilot mine."
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Firefly positioned for copper growth in Canada ahead of resource update Firefly Metals Ltd has reported drilling reports from its Green Bay copper-gold project in Newfoundland, ahead of a resource update
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.